Section 37-3403 – DEFINITIONS.
37-3403. DEFINITIONS. As used in this chapter: (1) "Department" means the state department of health and welfare. (2) "Director" means the director of the department. (3) "Entity" means: (a) The department; (b) A government entity; or (c) A private organization, whether for profit or nonprofit. History: [37-3403, added 2019, ch. 181, sec. 1, p. 584.]
Section 37-3404 – SYRINGE AND NEEDLE EXCHANGE PROGRAM.
37-3404. SYRINGE AND NEEDLE EXCHANGE PROGRAM. (1) Notwithstanding any provision of law to the contrary: (a) An entity may operate a syringe and needle exchange program in this state if such entity complies with the provisions of this section and with rules promulgated by the department; (b) An entity may procure supplies needed to operate […]
Section 37-3405 – REPORT.
37-3405. REPORT. No later than July 1, 2020, and every two (2) years thereafter, the department shall report to the senate and house of representatives health and welfare committees on: (1) The activities and outcomes of syringe and needle exchange programs operating in the state, including: (a) The number of individuals who have exchanged syringes […]
Section 37-3406 – RULES.
37-3406. RULES. The department may promulgate such rules as are necessary to enforce the provisions of this chapter. History: [37-3406, added 2019, ch. 181, sec. 1, p. 585.]
Section 37-3104 – USE OF DRUGS BY PHYSICIAN IN TREATMENT.
37-3104. USE OF DRUGS BY PHYSICIAN IN TREATMENT. A physician may use any drug or medicine which shall be authorized or released by a federal agency or authority with jurisdiction to so act; providing that the physician adheres to the criterion for the use of such drug or medicine as established by the federal agency […]
Section 37-3105 – REPORTS — FORM.
37-3105. REPORTS — FORM. Every physician that provides treatment or rehabilitation services to a person addicted to or dependent upon drugs shall each quarter of every year, commencing July 1, 1971, make a statistical report to the director of the department of health and welfare or his designee in such form and manner as the […]
Section 37-3301 – DEFINITIONS.
37-3301. DEFINITIONS. As used in this chapter: (1) "Pseudoephedrine product" means any compound, mixture or preparation containing any detectable quantity of pseudoephedrine, its salts or optical isomers, or salts of optical isomers. (2) "Retailer" means any person, other than a wholesaler, who sells or offers for sale or distributes at retail pseudoephedrine products, irrespective of […]
Section 37-3302 – SALES OF PSEUDOEPHEDRINE PRODUCTS.
37-3302. SALES OF PSEUDOEPHEDRINE PRODUCTS. A retailer shall ensure that: (1) Pseudoephedrine products offered for sale are located either in an area where the public is not permitted or inside a locked display case; and (2) All distributions of pseudoephedrine products are conducted by an employee of the retailer. No pseudoephedrine products shall be dispensed […]
Section 37-3303 – LIMITATIONS ON SALES AND PURCHASES.
37-3303. LIMITATIONS ON SALES AND PURCHASES. (1) It shall be unlawful for any retailer to knowingly sell, transfer or otherwise furnish in a single day a pseudoephedrine product or products containing more than a base amount of three and six-tenths (3.6) grams of pseudoephedrine. (2) It shall be unlawful for any person to knowingly purchase […]
Section 37-3303A – ELECTRONIC TRACKING SYSTEM.
37-3303A. ELECTRONIC TRACKING SYSTEM. (1) The board of pharmacy shall implement a real-time electronic sales tracking system to monitor the nonprescription sale of pseudoephedrine products in this state provided that such system is available to the state without charge for accessing the system to the state or retailers. If a real-time electronic sales tracking system […]